The Ace Inhibitor, Quinapril, Ameliorates Peritoneal Fibrosis in an Encapsulating Peritoneal Sclerosis Model in Mice

Author： Sawada T.   Ishii Y.   Tojimbara T.   Nakajima I.   Fuchinoue S.   Teraoka S.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.46, Iss.6, 2002-12, pp. : 505-510

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ciclosporin/mycophenolate/tacrolimus: Encapsulating peritoneal sclerosis?: 11 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1202, 2008-01 ,pp. : 10-11

Adis International

Access to resources Recommend Favorite

First Use of Tamoxifen in an HIV Patient with Encapsulating Peritoneal Sclerosis

By Mesquita M.   Guillaume M.P.   Dratwa M.  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 727-729

Adis International

Access to resources Recommend Favorite

Sirolimus: First report of encapsulating peritoneal sclerosis?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1398, 2012-01 ,pp. : 37-38

Adis International

Access to resources Recommend Favorite

Reduced inflammatory potential of peritoneal macrophages recruited in mice pretreated with a glycolipid synthesis inhibitor

By Yohe H.   Kitzmiller T.   Bement W.   Dwyer B.   Sinclair J.  

Inflammopharmacology, Vol. 14, Iss. 3-4, 2006-08 ,pp. : 155-160

Springer Publishing Company

Access to resources Recommend Favorite

Effects on Cytokines and Histology by Treatment with the Ace Inhibitor Captopril and the Antioxidant Retinoic Acid in the Monocrotaline Model of Experimentally Induced Lung Fibrosis

By  

Current Pharmaceutical Design, Vol. 13, Iss. 13, 2007-05 ,pp. : 1327-1333

Bentham Science Publishers

Access to resources Recommend Favorite